Findings

What do systematic reviews say?

3 questions · 3 findings · 3 reviews

No studies found 1 · 33.3%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 66.7%Moderate 0 · 0%High 0 · 0%

Serious adverse events · Patients with collagenous colitis

Mesalamine showed no clear difference in serious adverse events compared with placebo (low certainty).

1 finding from 1 review

Interventions for treating collagenous colitis 2017 · Cochrane Headline outcomes only
RR 4.44 [0.49, 40.29]
1 study · 62 participants
Low

Serious adverse events · Participants with Crohn's disease in remission

The review found no eligible studies for this question.

1 finding from 1 review

Enteral nutrition for maintenance of remission in Crohn's disease 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Serious adverse events · Adult patients with active ulcerative colitis

Budesonide showed no clear difference in serious adverse events compared with mesalamine (low certainty).

1 finding from 1 review

Oral budesonide for induction of remission in ulcerative colitis 2015 · Cochrane Headline outcomes only
RR 0.75 [0.17, 3.28]
1 study · 254 participants
Low